Lexaria Bioscience : Corporate Highlight Sheet -Today at 06:47 pm
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
Source: marketscreener.com
📰 Bioscience Corp News
Page 3 - Bioscience Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Corp. Real-time updates on events, politics, business and more.
North American Morning Briefing : Stocks Seen -2- - Today at 06:06 am
In a 2-1 ruling, the U.S. Court of Appeals for the Ninth Circuit agreed to a Biden administration request and blocked for now a lower court decision that would have barred the administration from...
Source: marketscreener.com
Twist Bioscience Stock Soars After Q3 Report - Here's Why - Twist Bioscience (NASDAQ:TWST)
Twist Bioscience Corp (NASDAQ: TWST) reported Q3 sales increased 14% Y/Y to $63.7 million, beating the consensus of $60.71 million.
Source: benzinga.com
Twist Bioscience Corp Q3 Loss decreases, beats estimates
Twist Bioscience Corp (TWST) reported Loss for third quarter that decreased from the same period last year and beat the Street estimates. The company's earnings came in at -$57.
Twist Bioscience Corp Thomson Reuters Bioscience Corp Analyst Estimates Wall Street Orporate Results
Source: rttnews.com
Lexaria Bioscience : Corporate Highlight Sheet
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
Source: marketscreener.com
Maureen Schafer accused of discrimination while at UNLV | Las Vegas Review-Journal
UNLV medical school former chief of staff was allowed to continue working despite repeated complaints
Las Vegas United States Shawn Gerstenberger Elda Luna Sidhu Bizuayehu Tesfaye Las Vegas Susan Carrasco Obrien
Source: reviewjournal.com
Lexaria Bioscience Corp.: Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers
DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utilityKELOWNA, BC / ACCESSWIRE / May 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company"
United States Gewinn Nur George Jurcic Philip Ainslie Company Or Lexaria Lexaria Bioscience Corp View
Source: finanznachrichten.de
Lexaria Bioscience Corp.: Lexaria's Human Clinical Nicotine Study Completes Dosing as Planned
KELOWNA, BC / ACCESSWIRE / May 8, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that dosing of the targeted
George Jurcic Exchange Commission Lexaria Bioscience Corp View Company Or Lexaria Drug Administration Lexaria Bioscience Corp
Source: finanznachrichten.de
Lexaria Bioscience : Corporate Highlight Sheet
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202... | May 1, 2023
Source: marketscreener.com
Lexaria Bioscience : Corporate Highlight Sheet
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202... | April 12, 2023
British Columbia United States Chris Bunka John Docherty British American Tobacco Lexaria Pharmaceutical Corp
Source: marketscreener.com